Pulmonx backs FY24 revenue view $81M-$84M, consensus $82.63M
PremiumThe FlyPulmonx backs FY24 revenue view $81M-$84M, consensus $82.63M
21d ago
Pulmonx presents clinical data from COVERT, LIBERATE trials at ERS
Premium
The Fly
Pulmonx presents clinical data from COVERT, LIBERATE trials at ERS
2M ago
Pulmonx price target raised to $16 from $15 at Canaccord
Premium
The Fly
Pulmonx price target raised to $16 from $15 at Canaccord
4M ago
Pulmonx Corporation’s Financial Outlook: Single-Product Reliance and Market Penetration Hurdles Threaten Profitability
PremiumCompany AnnouncementsPulmonx Corporation’s Financial Outlook: Single-Product Reliance and Market Penetration Hurdles Threaten Profitability
7M ago
Pulmonx price target lowered to $15 from $16 at Canaccord
Premium
The Fly
Pulmonx price target lowered to $15 from $16 at Canaccord
7M ago
Pulmonx sees FY24 revenue $81M-$84M, consensus $82.19M
Premium
The Fly
Pulmonx sees FY24 revenue $81M-$84M, consensus $82.19M
7M ago
Pulmonx downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyPulmonx downgraded to Equal Weight from Overweight at Wells Fargo
9M ago
Pulmonx price target raised to $20 from $18 at Craig-Hallum
Premium
The Fly
Pulmonx price target raised to $20 from $18 at Craig-Hallum
9M ago
Pulmonx price target raised to $16 from $15 at Canaccord
Premium
The Fly
Pulmonx price target raised to $16 from $15 at Canaccord
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100